Europe Biopharmaceutical Tubing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Plastic, Metal, and Silicone) and Application (Pharmaceutical, Medical Devices, Research and Development, and Others)

The silicone segment by type is estimated to lead the market growth during the forecast period.

According to a new market research study of “Europe Biopharmaceutical Tubing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Type, Application and Country.” The Europe biopharmaceutical tubing market is expected to reach US$ 1,474.45 million by 2028 from US$ 827.65 million in 2021; it is estimated to grow at a CAGR of 8.6% from 2021 to 2028. The report highlights trends prevailing in the Europe biopharmaceutical tubing market and the factors driving market along with those that act as hindrances.

Popularity of minimally invasive surgical procedures has increased in the recent years owing to the benefits such as tiny incisions, faster recovery of patients, and less discomfort caused to the patients. The growing prevalence of arthritis, cancer, and cardiovascular diseases, all of which require extensive surgical treatments, has boosted the demand for minimally invasive procedures. As a result, there is an enormous demand for catheters and biopharmaceutical tubing, among other components. Further, biopharmaceutical tubing systems are reasonably priced and aid in time-saving procedures. For example, employing catheter tubing for cardiac and urine catheterization significantly lowers the time required for the medical or surgical operation. Therefore, the growing demand for minimally invasive medical procedures and focus on increasing the efficiency of these procedures play an important role in propelling the demand for biopharmaceutical tubing. Also, growing use of platinum-cured silicone as material of choice for biopharmaceutical tubing offers several advantages over traditional peroxide cured tubing. For instance, in January 2020, Watson-Marlow Fluid Technology Group (WMFTG) launched BioPure silicone transfer tubing to confer safe, reliable, and cost-effective solution for a wide range of bioprocess fluid transfer applications. Therefore, the launch and use of platinum-cured silicone tubing as a material of choice is likely to emerge as a significant trend in the biopharmaceuticals market during the forecast period. Thus, there are significant opportunities for the market players to enter the market with superior and cost-effective products.

The COVID-19 pandemic has severely affected the industries in European Union (EU). As the number of COVID-19 patients requiring ventilatory support (high-flow oxygen therapy, non-invasive ventilation, invasive mechanical ventilation, and extracorporeal membrane oxygenation) has increased, the demand for medical tubing has also increased in the last year. In addition, growing COVID-19 infection in people with existing medical conditions such as asthma and diabetes is also influencing the growth of the market, which, in turn propel the demand for drug delivery devices and equipment such as nasogastric tubes, nebulizers, and spacer devices. Further, the presence of a robust industrial base and several established manufacturers of medical tubing in the country is strengthening the market growth in the country. These factors are expected to fuel the demand for biopharmaceutical tubing in the region during the forecast period.

The Europe biopharmaceutical tubing market, by type, is segmented into plastic, metal, and silicone. Based on application, the Europe biopharmaceutical tubing market is segmented into pharmaceutical, medical devices, research and development, and others. Geographically, the Europe biopharmaceutical tubing market can be segmented into UK, Germany, France, Italy, Spain and Rest of Europe.

W. L. Gore and Associates, Inc. Saint-Gobain Sekurit, Freudenberg Group, RAUMEDIC AG, TEKNI-PLEX, NewAge Industries, Inc, Optinova, Zeus Industrial Products, Inc. NORDSON CORPORATION and DuPont de Nemours, Inc. are among the leading companies operating in the Europe biopharmaceutical tubing market

Reasons to buy:

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe biopharmaceutical tubing market
• Highlights key business priorities in order to assist companies to realign their business strategies
• The key findings and recommendations highlight crucial progressive industry trends in the Europe biopharmaceutical tubing market, thereby allowing players across the value chain to develop effective long-term strategies
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
• Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.